Benign Prostatic Hyperplasia

5-ARIs May Protect Against Bladder Cancer Progression

Publish Date May 17, 2023

5α-reductase inhibitors are widely used to treat lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH).

Prostate Artery Embolization Effective Long Term for Prostate-Related Urinary Symptoms

Publish Date April 3, 2023

In less than 3 months after procedure, only mild urinary symptoms reported; benefits persisted through 6 years

High-Quality Surgical Videos Lacking for Vaporization of Prostate

Publish Date February 6, 2023

Average video score was 6.65; only 24.3% of videos emphasized critical steps of surgery

5-ARIs Linked With Depression, But Not Suicide Risk

Publish Date January 5, 2023

This Swedish population-based study has the largest sample size to date exploring these associations.

Poor Sleep Tied to Urinary, Prostate Symptoms

Publish Date December 12, 2022

Association especially strong among the elderly male population

Lipid Ratios Linked to Benign Prostatic Hyperplasia Risk

Publish Date November 18, 2022

TG/HDL-C and TC/HDL-C ratios associated with BPH; TG/HDL-C may be risk factor for BPH with normal TG, HDL-C

Drug Repurposing Study Shows PDE5 Inhibitors Do Not Reduce Dementia Risk

Publish Date October 14, 2022

By identifying existing medications that may be repurposed for dementia, clinicians may be able to provide faster treatment for those in need.

Erectile Function Mostly Not Impacted by Surgery for BPH

Publish Date September 22, 2022

But rate of retrograde ejaculation higher following many surgical procedures for benign prostatic hyperplasia

Urethral Dilation Prior to BPH Surgery Lowers Urethral Stricture Risk

Publish Date September 9, 2022

Investigators in South Korea demonstrated the benefit in a retrospective study that included 651 men undergoing transurethral resection of the prostate.

Long-Term Outcomes of ThuLEP Reported for Benign Prostatic Enlargement

Publish Date September 7, 2022

Rates of reinterventions low for persistence or regrowth of prostate adenoma, long-term complications.